The hospital CIO who is going to write your company a seven-figure check this year is not waiting for your pitch deck. She is on LinkedIn, right now, reading the last six months of your founder’s posts. If there are no posts, she is taking a meeting with the next vendor.
This is the shift that has reordered enterprise health tech sales in 2026. The center of gravity for trust in this category has moved off the company page and off the press release wire and onto the personal feed of the person whose name is on the door.
Most health tech CEOs have not yet absorbed what this means.
The Buyer Arrives Pre-Vetted, or Pre-Rejected
In a 9-to-18-month enterprise health tech sales cycle, the first filter is no longer the deck. It is a LinkedIn search for the founder. Hospital CIOs, health plan medical officers, and self-insured employer benefits leaders arrive at the first call having already read six months of the founder’s posts — or having read nothing at all, which is worse.
A founder feed that articulates a clear category thesis, engages with real clinical evidence, and demonstrates operating seriousness shortens the vetting portion of the sales cycle by weeks. A silent feed forces the sales team to earn trust from scratch every meeting. The math, run across a hundred opportunities a year, is enormous.
The Asymmetry is Still Huge
Industry analyses of LinkedIn’s roughly 135 million daily active users put the share who post any original content at around 5 percent. In health tech specifically, adjusting for the proportion of operators who are active versus passive on the platform, the share of founders posting consistently is lower still.
The platform is not crowded. It is empty.
A founder posting three substantive times a week is not competing with millions of peers for attention. They are competing with the 95 percent of their category that is not posting at all. The window narrows every quarter as more operators adopt the channel. 2026 is cheaper than 2027.
The Company Page Is Now the Supporting Act
LinkedIn’s 2025 B2B Marketing Benchmark and a string of independent engagement studies have converged on a finding that is uncomfortable for marketing teams: leader-shared and employee-shared posts outperform company-page posts by a factor of 5 to 10 on engagement. For founders with public-figure status, the multiple runs higher.
The implication: in 2026, the company page is the supporting act. The founder feed is the stage. If 80 percent of a health tech company’s written content still flows to the company page, at least half of it should be moved into founder-voice form. Not because the company page is dead, but because the audience has decided where the signal lives.
Three Patterns Worth Studying
The founders who have figured this out are not all loud. Andrew Dudum, co-founder and CEO of Hims & Hers Health, has used founder voice to carry the public-company narrative through earnings cycles and major moments, including the company’s 2025 Super Bowl ad. The feed reads as the founder, not the comms team — and consumer health markets respond to that distinction.
Kate Ryder, founder and CEO of Maven Clinic, has used a different pattern. Mission-driven, category-defining, consistently focused on women’s and family health economics. Maven has become shorthand for the category in part because the founder has been the loudest consistent voice defining it in public.
Glen Tullman, founder and CEO of Transcarent and previously CEO of Livongo, runs a quieter enterprise pattern. The feed leans operator. Employer benefits design. Health-plan economics. Member-experience data. The audience is the buyer, not the consumer. In enterprise health tech, where the sale is slow and the stakes are real, the second time-founder’s voice is a form of pre-sold credibility.
Three different audiences. Three different patterns. One shared insight: the founder is the most valuable channel the company owns, and it is not transferable to a marketing team.
The Operator’s Objection, Answered
Most health tech CEOs do not push back on whether founder voice matters. They push back on time. The honest answer: the model is interview-and-refine, not write-from-scratch. A communications partner runs a 45-minute recorded session per week with the founder covering three topics drawn from a clear category thesis. That transcript becomes three posts — one long-form narrative, one document carousel with data, one short founder-to-camera video. The founder reviews and posts.
Total founder time: roughly one hour per week.
Most public health tech CEOs sustaining a LinkedIn presence — including those running 500-plus person companies — are running some version of this model. It is the only one that survives first contact with a real operating calendar.
The Decision
Every health tech CEO in 2026 is making one of two decisions about LinkedIn, whether they realize it or not. They are either building a founder feed that compounds and shortens sales cycles, or they are conceding category voice to a competitor whose founder is posting three times a week.
The asymmetry will not last. The founders who claim category voice in the next four quarters will hold it. The ones who wait will be reading their competitor’s posts the same way their buyers already are.
Ronn Torossian is the founder and chairman of 5WPR, one of the largest independent public relations and digital marketing firms in the United States. He is the author of “For Immediate Release” and a contributor to Forbes, CNN, and CNBC.